Recurrent respiratory papillomatosis

Search with Google Search with Bing
Information
Disease name
Recurrent respiratory papillomatosis
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02632344 Active, not recruiting Phase 2 Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients April 2016 July 2024
NCT04724980 Active, not recruiting Phase 1/Phase 2 Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis March 16, 2021 June 2, 2026
NCT00550914 Completed Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP January 2007 June 2009
NCT00571701 Completed Phase 2 Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis February 2008 January 2015
NCT01020747 Completed Phase 1 Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP) November 2009 March 2011
NCT00038714 Completed Phase 2 A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis November 2001 January 2004
NCT00205374 Completed Phase 4 Use of Cidofovir for Recurrent Respiratory Papillomatosis November 1999 December 2009
NCT02217358 Completed N/A Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions February 2012 May 2016
NCT02592902 Completed N/A Recurrent Respiratory Papillomatosis and Extraesophageal Reflux April 2014 September 2018
NCT02859454 Completed Phase 2 Avelumab for People With Recurrent Respiratory Papillomatosis August 6, 2016 September 15, 2021
NCT03707587 Completed Phase 2 M7824 in People With Recurrent Respiratory Papillomatosis December 19, 2018 July 6, 2022
NCT04645602 Not yet recruiting Phase 2 Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement July 2024 December 1, 2027
NCT06412172 Recruiting The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) April 15, 2024 April 15, 2030
NCT01793168 Recruiting Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford July 2010 December 2100
NCT00747461 Terminated Phase 4 Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") October 2008 March 2011
NCT03465280 Unknown status Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP) April 1, 2018 August 31, 2022
NCT02854761 Unknown status Phase 1 Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) September 2016
NCT02555800 Unknown status Phase 2 Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis December 2014 June 2017
NCT01995721 Unknown status Phase 3 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children February 2014 February 2017
NCT00829608 Withdrawn Early Phase 1 Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis January 2009 June 2010
NCT01058317 Withdrawn Phase 2/Phase 3 Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis January 2010 September 2010
OrphaNumber from OrphaNet (Orphanet)
60032